Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

The right to know is for everyone.

Hook GE, Lucier GW.

Environ Health Perspect. 2000 Apr;108(4):A160-1. No abstract available.

2.

Endocrine disrupting chemicals research program of the U.S. Environmental Protection Agency: summary of a peer-review report.

Harding AK, Daston GP, Boyd GR, Lucier GW, Safe SH, Stewart J, Tillitt DE, Van Der Kraak G.

Environ Health Perspect. 2006 Aug;114(8):1276-82.

3.

Human consumption of methyleugenol and its elimination from serum.

Schecter A, Lucier GW, Cunningham ML, Abdo KM, Blumenthal G, Silver AG, Melnick R, Portier C, Barr DB, Barr JR, Stanfill SB, Patterson DG Jr, Needham LL, Stopford W, Masten S, Mignogna J, Tung KC.

Environ Health Perspect. 2004 May;112(6):678-80.

4.
5.

Regulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced tumor promotion by 17 beta-estradiol in female Sprague--Dawley rats.

Wyde ME, Eldridge SR, Lucier GW, Walker NJ.

Toxicol Appl Pharmacol. 2001 May 15;173(1):7-17.

PMID:
11350210
6.

Increased tumor necrosis factor-alpha production by peripheral blood leukocytes from TCDD-exposed rhesus monkeys.

Rier SE, Coe CL, Lemieux AM, Martin DC, Morris R, Lucier GW, Clark GC.

Toxicol Sci. 2001 Apr;60(2):327-37.

PMID:
11248145
7.
8.

Induction of lung lesions in female rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Tritscher AM, Mahler J, Portier CJ, Lucier GW, Walker NJ.

Toxicol Pathol. 2000 Nov-Dec;28(6):761-9.

PMID:
11127289
9.
10.

Levels of seven urinary phthalate metabolites in a human reference population.

Blount BC, Silva MJ, Caudill SP, Needham LL, Pirkle JL, Sampson EJ, Lucier GW, Jackson RJ, Brock JW.

Environ Health Perspect. 2000 Oct;108(10):979-82.

11.

Ovarian tumors in rats induced by chronic 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment.

Davis BJ, Mccurdy EA, Miller BD, Lucier GW, Tritscher AM.

Cancer Res. 2000 Oct 1;60(19):5414-9.

13.

Hepatocarcinogenesis in female Sprague-Dawley rats following discontinuous treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Walker NJ, Tritscher AM, Sills RC, Lucier GW, Portier CJ.

Toxicol Sci. 2000 Apr;54(2):330-7.

PMID:
10774815
14.

Levels of methyleugenol in a subset of adults in the general U.S. population as determined by high resolution mass spectrometry.

Barr DB, Barr JR, Bailey SL, Lapeza CR Jr, Beeson MD, Caudill SP, Maggio VL, Schecter A, Masten SA, Lucier GW, Needham LL, Sampson EJ.

Environ Health Perspect. 2000 Apr;108(4):323-8.

15.

Dose-dependent localization of TCDD in isolated centrilobular and periportal hepatocytes.

Santostefano MJ, Richardson VM, Walker NJ, Blanton J, Lindros KO, Lucier GW, Alcasey SK, Birnbaum LS.

Toxicol Sci. 1999 Nov;52(1):9-19.

PMID:
10568693
16.

Medicinal herbs in the United States: research needs.

Matthews HB, Lucier GW, Fisher KD.

Environ Health Perspect. 1999 Oct;107(10):773-8.

17.

Preparing for the new millennium.

Hook GE, Lucier GW.

Environ Health Perspect. 1999 Apr;107(4):A180. No abstract available.

18.

Why not use it all?

Lucier GW.

Environ Health Perspect. 1999 May;107(5):A232-3. No abstract available.

19.

Quantitative analysis of constitutive and 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced cytochrome P450 1B1 expression in human lymphocytes.

Spencer DL, Masten SA, Lanier KM, Yang X, Grassman JA, Miller CR, Sutter TR, Lucier GW, Walker NJ.

Cancer Epidemiol Biomarkers Prev. 1999 Feb;8(2):139-46.

20.

Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Walker NJ, Portier CJ, Lax SF, Crofts FG, Li Y, Lucier GW, Sutter TR.

Toxicol Appl Pharmacol. 1999 Feb 1;154(3):279-86.

PMID:
9931287
21.

Public health policy and the National Toxicology Program.

Lucier GW, Barrett JC.

Environ Health Perspect. 1998 Oct;106(10):A470-1. No abstract available.

22.

Human exposure assessment and the National Toxicology Program.

Lucier GW, Schecter A.

Environ Health Perspect. 1998 Oct;106(10):623-7.

23.
24.

Cautionary reflections.

Hook GE, Lucier GW.

Environ Health Perspect. 1998 Apr;106(4):A168-9. No abstract available.

25.

Animal models of human response to dioxins.

Grassman JA, Masten SA, Walker NJ, Lucier GW.

Environ Health Perspect. 1998 Apr;106 Suppl 2:761-75. Review.

26.
27.

Environmental Health Information Service.

Hook GE, Lucier GW.

Environ Health Perspect. 1997 Oct;105(10):1028. No abstract available.

28.

Synergy, antagonism, and scientific process.

Hook GE, Lucier GW.

Environ Health Perspect. 1997 Aug;105(8):784. No abstract available.

29.

Dose-response relationships for endocrine disruptors: what we know and what we don't know.

Lucier GW.

Regul Toxicol Pharmacol. 1997 Aug;26(1 Pt 1):34-5. Review. No abstract available.

PMID:
9339476
30.

Anniversaries and attitudes.

Hook GE, Lucier GW.

Environ Health Perspect. 1997 Apr;105(4):360. No abstract available.

31.

Contribution of genetic and nutritional factors to DNA damage in heavy smokers.

Mooney LA, Bell DA, Santella RM, Van Bennekum AM, Ottman R, Paik M, Blaner WS, Lucier GW, Covey L, Young TL, Cooper TB, Glassman AH, Perera FP.

Carcinogenesis. 1997 Mar;18(3):503-9.

PMID:
9067549
32.

Isolation and characterization of a novel gene induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver.

Selmin O, Lucier GW, Clark GC, Tritscher AM, Vanden Heuvel JP, Gastel JA, Walker NJ, Sutter TR, Bell DA.

Carcinogenesis. 1996 Dec;17(12):2609-15.

PMID:
9006096
34.

Workshop overview. National Toxicology Program Studies: principles of dose selection and applications to mechanistic based risk assessment.

Bucher JR, Portier CJ, Goodman JI, Faustman EM, Lucier GW.

Fundam Appl Toxicol. 1996 May;31(1):1-8.

PMID:
8998945
35.

Differences in binding of epidermal growth factor to liver membranes of TCDD-resistant and TCDD-sensitive rats after a single dose of TCDD.

Tuomisto J, Sewall CH, Unkila M, Pohjanvirta R, Clark GC, Viluksela M, Rozman K, Lucier GW.

Environ Toxicol Pharmacol. 1996 Apr 15;1(2):109-16.

PMID:
21781670
36.

Increased oxidative DNA damage in livers of 2,3,7,8-tetrachlorodibenzo-p-dioxin treated intact but not ovariectomized rats.

Tritscher AM, Seacat AM, Yager JD, Groopman JD, Miller BD, Bell D, Sutter TR, Lucier GW.

Cancer Lett. 1996 Jan 2;98(2):219-25.

PMID:
8556712
37.

Mechanism-based toxicology in cancer risk assessment: implications for research, regulation, and legislation.

Lucier GW.

Environ Health Perspect. 1996 Jan;104(1):84-8. No abstract available.

38.

Receptor-mediated carcinogenesis: the role of biological effect modeling for risk assessment of dioxin and tamoxifen.

Demby KB, Lucier GW.

Prog Clin Biol Res. 1996;394:113-29. Review. No abstract available.

PMID:
8778793
39.

A mechanistic model of effects of dioxin on thyroid hormones in the rat.

Kohn MC, Sewall CH, Lucier GW, Portier CJ.

Toxicol Appl Pharmacol. 1996 Jan;136(1):29-48.

PMID:
8560478
40.

Receptor-mediated events and the evaluation of the Environmental Protection Agency (EPA) of dioxin risks.

Sewall CH, Lucier GW.

Mutat Res. 1995 Dec;333(1-2):111-22. Review. No abstract available.

PMID:
8538618
41.

Induced gene transcription: implications for biomarkers.

Sewall CH, Bell DA, Clark GC, Tritscher AM, Tully DB, Vanden Heuvel J, Lucier GW.

Clin Chem. 1995 Dec;41(12 Pt 2):1829-34. Review.

42.
43.

Rat CYP1B1: an adrenal cytochrome P450 that exhibits sex-dependent expression in livers and kidneys of TCDD-treated animals.

Walker NJ, Gastel JA, Costa LT, Clark GC, Lucier GW, Sutter TR.

Carcinogenesis. 1995 Jun;16(6):1319-27.

PMID:
7788849
44.

TCDD reduces rat hepatic epidermal growth factor receptor: comparison of binding, immunodetection, and autophosphorylation.

Sewall CH, Clark GC, Lucier GW.

Toxicol Appl Pharmacol. 1995 Jun;132(2):263-72.

PMID:
7785053
45.

Alterations in thyroid function in female Sprague-Dawley rats following chronic treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Sewall CH, Flagler N, Vanden Heuvel JP, Clark GC, Tritscher AM, Maronpot RM, Lucier GW.

Toxicol Appl Pharmacol. 1995 Jun;132(2):237-44.

PMID:
7540335
46.

Attitudes affect behavior.

Hook GE, Lucier GW.

Environ Health Perspect. 1995 Apr;103(4):318. No abstract available.

47.

Considerations concerning the murine hepatocarcinogenicity of selected chlorinated hydrocarbons.

Maronpot RR, Anna CH, Devereux TR, Lucier GW, Butterworth BE, Anderson MW.

Prog Clin Biol Res. 1995;391:305-23. Review.

PMID:
8532724
48.

Not your average Joe.

Lucier GW.

Environ Health Perspect. 1995 Jan;103(1):10. No abstract available.

49.

The importance of biological realism in dioxin risk assessment models.

Kohn MC, Lucier GW, Portier CJ.

Risk Anal. 1994 Dec;14(6):993-1000.

PMID:
7846331
50.

Risk from low-dose exposures.

Portier CJ, Lucier GW, Edler L.

Science. 1994 Nov 18;266(5188):1141-2. No abstract available.

PMID:
7973685

Supplemental Content

Loading ...
Support Center